I recently received an email from Partners, looking for ITP patients to participate in a study about treatments and experiences living with ITP.
Partners, is a consulting firm located in Boston, Massachusetts (USA) working to understand people’s experiences living with Immune Thrombocytopenic Purpura (ITP) and your experiences with IVIG, SCIG, and TPE treatments. Your input will help focus research efforts to areas where they will have the greatest impact.
The goal of the study is to better understand your experiences in living with ITP and your treatment experiences with Intravenous Immunoglobulin (IVIG), subcutaneous immunoglobulin (SCIG), and/or plasma exchange (TPE, plasmapheresis). Your responses will directly help our client – a healthcare company – make more informed decisions.
If you have had any of the above treatments and are interested in being compensated for your time, please contact Ben Shedlock via email at BEN.SHEDLOCK@rarepatientvoice.com
ITP Patient Market Research Flyer